<DOC>
	<DOCNO>NCT01372917</DOCNO>
	<brief_summary>The study prospective multi-centered cohort study design determine safety efficacy AlloMax immediate expander-based breast reconstruction . Specifically , study design determine sterility human acellular dermal matrix result low incidence infection seroma . The study determine gamma radiation , method terminally sterilize human acellular dermal matrix , negative impact graft incorporation host tissue .</brief_summary>
	<brief_title>Evaluating AlloMax Immediate Expander-Based Breast Reconstruction Study</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Patients immediate breast reconstruction tissue expanders Unilateral bilateral reconstruction Ages 25 65 All breast cancer stag type BMI &gt; 35 Active smoker Diabetics History radiation plan radiation Immunocompromised patient</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>